Table 2 Clinical and laboratory parameters of ECLS recipients

Baseline characteristics

Age, years

48.07 ± 20.12

59.72 ± 14.39

0.015

Sex, male

22 (78.6%)

22 (75.9%)

0.807

Current smoking

7 (25.0%)

11 (37.9%)

0.294

Pre-existing comorbidity

Diabetes mellitus

7 (25.0%)

8 (27.6%)

0.825

Hypertension

10 (35.7%)

9 (31.0%)

0.708

Stroke

0 (0%)

2 (6.9%)

0.157

Chronic obstructive pulmonary disease

2 (7.1%)

1 (3.4%)

0.532

End-stage renal disease

2 (7.1%)

1 (3.4%)

0.532

Coronary artery disease

7 (25.0%)

6 (20.7%)

0.698

Prior myocardial infarction

0 (0%)

3 (10.3%)

0.080

Heart failure

6 (21.4%)

11 (37.9%)

0.173

CPR, yes or no

6 (21.4%)

10 (34.5%)

0.273

IABP insertion, yes or no

5 (17.9%)

5 (17.2%)

0.951

Indication of ECLS

0.516

Cardiogenic

16 (57.1%)

19 (65.5%)

Non-cardiogenic

12 (42.9%)

10 (34.5%)

Duration of ECLS, day

38.57 ± 31.34

11.69 ± 14.61

<0.001

Inotropic equivalent, μg/kg per minute

70.46 ± 198.44

29.42 ± 27.09

0.275

Clinical parameters

APACHE score

16.75 ± 7.18

21.83 ± 7.45

0.011

SOFA score

7.71 ± 4.35

9.66 ± 3.42

0.066

LODS

7.61 ± 3.73

10.86 ± 3.59

0.001

MODS

9.61 ± 4.00

12.24 ± 3.59

0.011

Mean arterial pressure, mm Hg

72.38 ± 27.68

63.15 ± 22.10

0.169

Central venous pressure, mmHg

15.17 ± 6.29

16.83 ± 5.93

0.356

Laboratory parameters

pH

7.29 ± 0.17

7.29 ± 0.20

0.895

PaCO₂, mmHg

43.76 ± 25.64

47.95 ± 33.32

0.598

HCO₃, mmol/L

19.48 ± 6.11

20.95 ± 6.76

0.392

Lactate, mmol/L

7.91 ± 5.96

6.87 ± 6.29

0.579

White blood cell count, /μl

13956.40 ± 6512.84

12597.93 ± 82

0.510

Hematocrit, %

34.72 ± 7.20

35.48 ± 7.62

0.711

Blood urea nitrogen, mg/dl

27.23 ± 20.65

38.33 ± 31.63

0.140

Creatinine, mg/dl

1.98 ± 1.75

2.35 ± 2.58

0.551

Total bilirubin, mg/dl

2.31 ± 3.80

2.09 ± 2.22

0.812

Creatinine phosphokinase, U/L

3656.47 ± 8632.73

1064.45 ± 1732.63

0.270

Creatinine phosphokinase-MB

240.82 ± 634.20

87.86 ± 147.04

0.409